| Name | KRAS G12C inhibitor 39 |
|---|
| Description | KRAS G12C inhibitor 39 is a potent inhibitor of KRAS G12C. KRas is a highly attractable target of the pharmaceutical industry for cancer research. KRAS G12C inhibitor 39 has the potential for the research of KRAS G12C-mediated cancer (extracted from patent WO2019099524A1, compound 494)[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. James F. Blake, et al. Kras g12c inhibitors. Patent WO2019099524A1. |
| Molecular Formula | C37H43N9O2 |
|---|---|
| Molecular Weight | 645.80 |